FOUNDATION RESOURCE MANAGEMENT INC
EndowmentPosition in NVO — Novo Nordisk A S
CIK 1179232
LITTLE ROCK, AR
Position in NVO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$8,525,553
+$2,126,423 QoQ
Shares Held
177,838
+2.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#162
of 1,348 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOUNDATION RESOURCE MANAGEMENT INC holds $80,220,075 across 6 Drug Manufacturers - General names. NVO ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
202,690 | $26,045,665 | |
| 2 | PFE |
Pfizer Inc
|
936,078 | $22,540,758 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
102,147 | $12,905,251 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
171,716 | $9,894,275 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
177,838 | $8,525,553 | |
| 6 | JNJ |
Johnson & Johnson
|
1,215 | $308,573 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,525,553 | 177,838 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $6,399,130 | 174,126 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $8,589,256 | 168,814 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $9,309,335 | 167,766 | Shares | Sole | 2025-10-14 | |
| No filing history on record for this holder in this stock. | ||||||